Suggested pathway to assess radiation safety of 11C-labeled PET tracers for first-in-human studies.
作者信息
Zanotti-Fregonara Paolo, Innis Robert B
出版信息
Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):544-7. doi: 10.1007/s00259-011-2005-8. Epub 2011 Dec 8.
Abstract
摘要
相似文献
1
Suggested pathway to assess radiation safety of 11C-labeled PET tracers for first-in-human studies.用于人体首次研究的11C标记PET示踪剂辐射安全性评估的建议流程。
Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):544-7. doi: 10.1007/s00259-011-2005-8. Epub 2011 Dec 8.
2
Suggested pathway to assess radiation safety of ¹⁸F-labeled PET tracers for first-in-human studies.评估用于人体首次研究的¹⁸F标记PET示踪剂辐射安全性的建议途径。
Eur J Nucl Med Mol Imaging. 2013 Oct;40(11):1781-3. doi: 10.1007/s00259-013-2512-x. Epub 2013 Jul 19.
3
Efficient preparation of [11C]CH3Br for the labeling of [11C]CH3-containing tracers in positron emission tomography clinical practice.在正电子发射断层扫描临床实践中高效制备用于标记含[¹¹C]CH₃示踪剂的[¹¹C]CH₃Br。
Nucl Med Commun. 2011 Jun;32(6):466-74. doi: 10.1097/MNM.0b013e3283438f9a.
4
Radiosynthesis of carbon-11-labeled camptothecin derivatives as potential positron emission tomography tracers for imaging of topoisomerase I in cancers.碳-11标记的喜树碱衍生物的放射性合成，作为用于癌症中拓扑异构酶I成像的潜在正电子发射断层扫描示踪剂。
Bioorg Med Chem Lett. 2005 Sep 1;15(17):3865-9. doi: 10.1016/j.bmcl.2005.05.108.
5
Imaging with (11)Carbon labelled PET tracers.使用碳-11标记的正电子发射断层显像（PET）示踪剂进行成像。
Nucl Med Commun. 2010 Jul;31(7):613-6. doi: 10.1097/MNM.0b013e32833c42ef.
6
Rapid feasibility studies of tracers for positron emission tomography: high-resolution PET in small animals with kinetic analysis.正电子发射断层显像示踪剂的快速可行性研究：基于动力学分析的小动物高分辨率PET
J Cereb Blood Flow Metab. 1991 Nov;11(6):926-31. doi: 10.1038/jcbfm.1991.157.
7
Evaluation of deuterated 18F- and 11C-labeled choline analogs for cancer detection by positron emission tomography.通过正电子发射断层扫描评估氘代 18F-和 11C-标记的胆碱类似物用于癌症检测。
Clin Cancer Res. 2012 Feb 15;18(4):1063-72. doi: 10.1158/1078-0432.CCR-11-2462. Epub 2012 Jan 10.
8
PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.使用新型示踪剂对胶质瘤进行正电子发射断层显像（PET）：一位等待被亲吻的睡美人。
Expert Rev Anticancer Ther. 2010 May;10(5):609-13. doi: 10.1586/era.10.37.
9
Development and evaluation of [C]DPA-813 and [F]DPA-814: novel TSPO PET tracers insensitive to human single nucleotide polymorphism rs6971.新型TSPO PET示踪剂[C]DPA - 813和[F]DPA - 814的研发与评估：对人类单核苷酸多态性rs6971不敏感
Eur J Nucl Med Mol Imaging. 2025 Jun;52(7):2658-2670. doi: 10.1007/s00259-025-07109-1. Epub 2025 Feb 5.
10
Development of carbon-11 labelled PET tracers-radiochemical and technological challenges in a historic perspective.碳-11标记正电子发射断层显像（PET）示踪剂的发展——从历史角度看放射化学和技术挑战
J Labelled Comp Radiopharm. 2015 Mar;58(3):65-72. doi: 10.1002/jlcr.3258. Epub 2015 Feb 13.
引用本文的文献
1
Radiation dosimetry of [C]TZ1964B as determined by whole-body PET imaging of nonhuman primates.通过非人灵长类动物的全身正电子发射断层显像（PET）成像测定的[C]TZ1964B的辐射剂量学
EJNMMI Res. 2025 May 14;15(1):57. doi: 10.1186/s13550-025-01221-x.
2
In vivo quantification of [C]BIO-1819578 in non-human primates, a novel radioligand for O-GlcNAcase.新型O-GlcNAcase放射性配体[C]BIO-1819578在非人类灵长类动物体内的定量分析。
J Cereb Blood Flow Metab. 2025 Apr 12:271678X251332487. doi: 10.1177/0271678X251332487.
3
Good Manufacturing Practice Validation and Radiation Dosimetry for the Clinical Application of a Novel α7-nAChR Radioligand: [C]KIn83.新型α7-烟碱型乙酰胆碱受体放射性配体[C]KIn83临床应用的药品生产质量管理规范验证与辐射剂量测定
Molecules. 2025 Mar 18;30(6):1356. doi: 10.3390/molecules30061356.
4
Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [C]CHDI-00485180-R and [C]CHDI-00485626, designed for quantification of cerebral aggregated mutant huntingtin.用于定量检测脑聚集型突变 huntingtin 的 PET 放射性配体 [C]CHDI-00485180-R 和 [C]CHDI-00485626 在健康人体志愿者中的生物分布和剂量学。
Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):48-60. doi: 10.1007/s00259-022-05945-z. Epub 2022 Aug 24.
5
Whole-Body PET Imaging in Humans Shows That C-PS13 Is Selective for Cyclooxygenase-1 and Can Measure the In Vivo Potency of Nonsteroidal Antiinflammatory Drugs.人体全身 PET 成像显示 C-PS13 对环氧化酶-1 具有选择性，并可测量非甾体抗炎药的体内效力。
J Nucl Med. 2023 Jan;64(1):159-164. doi: 10.2967/jnumed.122.264061. Epub 2022 Jul 7.
6
Modulation of Secondary Cancer Risks from Radiation Exposure by Sex, Age and Gonadal Hormone Status: Progress, Opportunities and Challenges.性别、年龄和性腺激素状态对辐射暴露所致继发性癌症风险的调节作用：进展、机遇与挑战
J Pers Med. 2022 Apr 30;12(5):725. doi: 10.3390/jpm12050725.
7
Target occupancy study and whole-body dosimetry with a MAGL PET ligand [C]PF-06809247 in non-human primates.使用MAGL PET配体[C]PF-06809247在非人灵长类动物中进行靶点占有率研究和全身剂量测定。
EJNMMI Res. 2022 Mar 4;12(1):13. doi: 10.1186/s13550-022-00882-2.
8
Radiation Absorbed Dose to the Embryo and Fetus from Radiopharmaceuticals.放射性药物致胚胎和胎儿的辐射吸收剂量。
Semin Nucl Med. 2022 Mar;52(2):140-148. doi: 10.1053/j.semnuclmed.2021.12.007. Epub 2022 Jan 21.
9
Human biodistribution and dosimetry of [C]-UCB-J, a PET radiotracer for imaging synaptic density.用于突触密度成像的正电子发射断层显像（PET）放射性示踪剂[C]-UCB-J的人体生物分布与剂量测定
EJNMMI Phys. 2021 Apr 23;8(1):37. doi: 10.1186/s40658-021-00384-5.
10
Biodistribution and radiation dosimetry of the positron emission tomography probe for AMPA receptor, [C]K-2, in healthy human subjects.AMPA 受体正电子发射断层扫描探针 [C]K-2 在健康人体中的生物分布和辐射剂量学。
Sci Rep. 2021 Jan 15;11(1):1598. doi: 10.1038/s41598-021-81002-3.
本文引用的文献
1
Human biodistribution and dosimetry of ¹¹C-CUMI-101, an agonist radioligand for serotonin-1a receptors in brain.¹¹C-CUMI-101 在脑内 5-羟色胺 1a 受体激动剂放射性配体的人体生物分布和剂量学研究。
PLoS One. 2011;6(9):e25309. doi: 10.1371/journal.pone.0025309. Epub 2011 Sep 27.
2
Biodistribution and radiation dosimetry of the glycine transporter-1 ligand 11C-GSK931145 determined from primate and human whole-body PET.从灵长类动物和人体全身 PET 确定甘氨酸转运蛋白-1 配体 11C-GSK931145 的生物分布和辐射剂量学。
Mol Imaging Biol. 2011 Aug;13(4):776-84. doi: 10.1007/s11307-010-0398-6.
3
Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.11C 标记多西他赛在癌症患者中的生物分布和辐射剂量学。
Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1950-8. doi: 10.1007/s00259-010-1489-y. Epub 2010 May 27.
4
Biodistribution and dosimetry in humans of two inverse agonists to image cannabinoid CB1 receptors using positron emission tomography.两种反向激动剂通过正电子发射断层扫描（PET）对大麻素 CB1 受体进行成像的人体生物分布和剂量学。
Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1499-506. doi: 10.1007/s00259-010-1411-7. Epub 2010 Mar 24.
5
Biodistribution and radiation dosimetry of [(11)C]choline: a comparison between rat and human data.[(11)C]胆碱的生物分布和辐射剂量学：大鼠和人体数据的比较。
Eur J Nucl Med Mol Imaging. 2010 May;37(5):874-83. doi: 10.1007/s00259-009-1346-z. Epub 2010 Jan 13.
6
PET-derived biodistribution and dosimetry of the benzodiazepine receptor-binding radioligand (11)C-(R)-PK11195 in children and adults.正电子发射断层扫描衍生的苯二氮䓬受体结合放射性配体 (11)C-(R)-PK11195 在儿童和成人中的生物分布和剂量学。
J Nucl Med. 2010 Jan;51(1):139-44. doi: 10.2967/jnumed.109.066472. Epub 2009 Dec 15.
7
Human biodistribution and radiation dosimetry of 11C-(R)-PK11195, the prototypic PET ligand to image inflammation.11C-（R）-PK11195 的人体生物分布和辐射剂量学研究，这是一种用于炎症成像的典型 PET 配体。
Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):606-12. doi: 10.1007/s00259-009-1298-3. Epub 2009 Oct 28.
8
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PET.通过正电子发射断层扫描（PET）测定D2/3激动剂11C-N-丙基去甲阿朴吗啡（11C-NPA）在人体的生物分布和剂量测定。
J Nucl Med. 2009 May;50(5):814-7. doi: 10.2967/jnumed.108.058131. Epub 2009 Apr 16.
9
Human brain imaging and radiation dosimetry of 11C-N-desmethyl-loperamide, a PET radiotracer to measure the function of P-glycoprotein.用于测量P-糖蛋白功能的PET放射性示踪剂11C-N-去甲基洛哌丁胺的人脑成像与辐射剂量测定
J Nucl Med. 2009 May;50(5):807-13. doi: 10.2967/jnumed.108.058453. Epub 2009 Apr 16.
10
Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agent.11C-卡芬太尼的剂量测定，一种微阿片受体显像剂。
Nucl Med Commun. 2009 Apr;30(4):314-8. doi: 10.1097/MNM.0b013e328329a0ec.
Zotero 插件